Who Buys Fenofibrate from India — 368 Importers Behind a $73.4M Market
India's fenofibrate import market is served by 368 active buyers who collectively imported $73.4M across 2,794 shipments. YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM) leads with a 8.4% market share, followed by MYLAN HUNGARY KFT and LIFESTAR PHARMA LLC. The top 5 buyers together control 32.3% of total import value, reflecting a moderately competitive buyer landscape.
Top Fenofibrate Importers — Ranked by Import Value
YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM) is the leading fenofibrate importer from India, holding a 8.4% share of the $73.4M market across 2,794 shipments from 368 buyers. The top 5 buyers — YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM), MYLAN HUNGARY KFT (FRANCE), LIFESTAR PHARMA LLC (UNITED STATES), MYLAN LABORATORIES SAS (FRANCE), CIPLA USA INC UPS SUPPLY CHAIN SOLU (UNITED STATES) — collectively control 32.3% of total import value.
Top Fenofibrate Buyers & Importers
Ranked by import value · 368 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | YUSEN LOGISTICS BENELUX BELGIUMBELGIUM FENOFIBRATE CAPSULES 200MG PACK :4X7S BAFENOFIBRATE CAPSULES 200MG PACK : 4X7S BFENOFIBRATE CAPSULES 267MG PACK : 4X7S B | $6.2M | 5 | 8.4% |
| 2 | MYLAN HUNGARY KFTFRANCE FENOFIBRATE TAB 145MGFENOFIBRATE TABLETFENOFIBRATE 145MG TABLET | $5.8M | 5 | 7.8% |
| 3 | LIFESTAR PHARMA LLCUNITED STATES FENOFIBRATE TABLETFENOFIBRATE 145MG TABLETFENOFIBRATE CAPSULES USP 134 MG | $4.7M | 5 | 6.3% |
| 4 | MYLAN LABORATORIES SASFRANCE FENOFIBRATE TAB 145MGFENOFIBRATE TABLETFENOFIBRATE 145MG TABLET | $3.9M | 5 | 5.4% |
| 5 | CIPLA USA INC UPS SUPPLY CHAIN SOLUUNITED STATES FENOFIBRATE TABLETFENOCOL 145 MG TABLETFENOFIBRATE 145MG TABLET | $3.2M | 5 | 4.3% |
| 6 | AMNEAL PHARMACEUTICALS, LLC (KY)UNITED STATES FENOFIBRATE TABLETFENOFIBRATE 145MG TABLETFENOFIBRATE CAPSULES USP 134 MG | $2.7M | 5 | 3.7% |
| 7 | DIRECT CUSTOMER SOLUTIONS LLCUNITED STATES FENOFIBRATE TABLETFENOFIBRATE 145MG TABLETFENOFIBRATE CAPSULES USP 134 MG | $2.5M | 5 | 3.3% |
| 8 | ARROW PHARMACEUTICALS PTY LTD,AUSTRALIA FENOCOL 145 MG TABLETFENOFIBRATE TABLETFENOFIBRATE TABLETNOS | $2.2M | 5 | 3.0% |
| 9 | MYLAN PHARMACEUTICALS INC,UNITED STATES FENOFIBRATE TAB 145MGFENOFIBRATE TABLETFENOFIBRATE 145MG TABLET | $1.7M | 5 | 2.4% |
| 10 | AJANTA PHARMA PHILIPPINES INCPHILIPPINES FENOFIBRATE TABLETFENOFIBRATE 145MG TABLETFENOFIBRATE CAPSULES USP 134 MG | $1.5M | 5 | 2.1% |
| 11 | AJANTA PHARMA USA INC. C/O RXCROSSRUNITED STATES FENOFIBRATE TABLETFENOFIBRATE 145MG TABLETFENOFIBRATE CAPSULES USP 134 MG | $1.3M | 5 | 1.8% |
| 12 | MYLAN PHARMACEUTICALS INCUNITED STATES FENOFIBRATE TAB 145MGFENOFIBRATE TABLETFENOFIBRATE 145MG TABLET | $1.2M | 5 | 1.6% |
| 13 | HANLIM PHARM. CO., LTD.SOUTH KOREA FENOFIBRATE PELLETS CAS NO. 49562-28-9FENOFIBRATE PELLETS | $1.2M | 5 | 1.6% |
| 14 | CIPLA USA INC UPS SUPPLY CHAIN SOLUNITED STATES FENOFIBRATE TABLETFENOCOL 145 MG TABLETFENOFIBRATE 145MG TABLET | $1.2M | 5 | 1.6% |
| 15 | HANLIM PHARM CO LIMITEDSOUTH KOREA FENOFIBRATE PELLETS CAS NO. 49562-28-9FENOFIBRATE PELLETS | $992.5K | 5 | 1.4% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Fenofibrate — and from which countries?
Flow of Fenofibrate exports from India: each country's share and the named importers behind the numbers
Fenofibrate — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $31.8M through 763 shipments. This represents a market share of 43.4% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• LIFESTAR PHARMA LLC - $4.7M (14.6% of country's total business)
• CIPLA USA INC UPS SUPPLY CHAIN SOLU - $3.2M (10.0% of country's total business)
• AMNEAL PHARMACEUTICALS, LLC (KY) - $2.7M (8.5% of country's total business)
• DIRECT CUSTOMER SOLUTIONS LLC - $2.5M (7.7% of country's total business)
• MYLAN PHARMACEUTICALS INC, - $1.7M (5.5% of country's total business)
• Rest of United States's importers - $17.1M (53.7% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $41.7K, indicating premium pricing strategy compared to the market average of $26.3K.
United States is a key market for Fenofibrate imports, representing 43.4% of total trade value.
2Belgium
Belgium emerges as the second largest importing country, achieving a total trade value of $6.4M through 74 shipments. This represents a market share of 8.7% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Belgium has a diverse importer base, with their top importers including:
• YUSEN LOGISTICS BENELUX BELGIUM - $6.2M (97.0% of country's total business)
Key Insight: Belgium demonstrates strong market positioning with an average shipment value of $86.0K, indicating premium pricing strategy compared to the market average of $26.3K.
Belgium is a key market for Fenofibrate imports, representing 8.7% of total trade value.
3Australia
Australia emerges as the third largest importing country, achieving a total trade value of $6.0M through 14 shipments. This represents a market share of 8.2% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Australia has a diverse importer base, with their top importers including:
• ARROW PHARMACEUTICALS PTY LTD, - $2.2M (36.8% of country's total business)
Key Insight: Australia demonstrates strong market positioning with an average shipment value of $429.2K, indicating premium pricing strategy compared to the market average of $26.3K.
Australia is a key market for Fenofibrate imports, representing 8.2% of total trade value.
4South Korea
South Korea emerges as the fourth largest importing country, achieving a total trade value of $4.7M through 9 shipments. This represents a market share of 6.4% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: South Korea has a diverse importer base, with their top importers including:
• HANLIM PHARM. CO., LTD. - $1.2M (25.3% of country's total business)
• HANLIM PHARM CO LIMITED - $992.5K (21.1% of country's total business)
• HANLIM PHARM. CO., LTD - $962.5K (20.5% of country's total business)
Key Insight: South Korea demonstrates strong market positioning with an average shipment value of $521.8K, indicating premium pricing strategy compared to the market average of $26.3K.
South Korea is a key market for Fenofibrate imports, representing 6.4% of total trade value.
5France
France emerges as the fifth largest importing country, achieving a total trade value of $4.7M through 44 shipments. This represents a market share of 6.4% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: France has a diverse importer base, with their top importers including:
• MYLAN HUNGARY KFT - $5.8M (123.5% of country's total business)
• MYLAN LABORATORIES SAS - $3.9M (84.4% of country's total business)
Key Insight: France demonstrates strong market positioning with an average shipment value of $105.9K, indicating premium pricing strategy compared to the market average of $26.3K.
France is a key market for Fenofibrate imports, representing 6.4% of total trade value.
Buyer Segment Analysis
TransData Nexus Fenofibrate buyer market intelligence
1Buyer Segment Analysis
The importers of Fenofibrate from India can be categorized into several key segments:
1. Distributors: Entities like YUSEN LOGISTICS BENELUX BELGIUM and MYLAN HUNGARY KFT fall into this category. These organizations purchase large quantities of Fenofibrate to distribute across various markets, ensuring a steady supply chain to meet regional demands. Their buying behavior typically involves bulk orders with a focus on cost-effectiveness and timely delivery.
2. Contract Manufacturers: Companies such as MYLAN LABORATORIES SAS and AMNEAL PHARMACEUTICALS, LLC (KY) serve as contract manufacturers. They procure Fenofibrate to produce finished pharmaceutical products under contract for other brands or for their own distribution. Their procurement patterns are aligned with production schedules and client demands, often involving consistent, large-volume purchases.
3. Retail Chains: Entities like LIFESTAR PHARMA LLC and CIPLA USA INC UPS SUPPLY CHAIN SOLU represent retail chains. They import Fenofibrate to supply their retail outlets, ensuring product availability for end consumers. Their purchasing behavior is influenced by consumer demand trends, leading to regular orders that align with market consumption rates.
4. Re-exporters: Companies such as ARROW PHARMACEUTICALS PTY LTD and AJANTA PHARMA PHILIPPINES INC act as re-exporters. They import Fenofibrate with the intention of exporting it to other countries, often leveraging favorable trade agreements or regional demand. Their order patterns are strategic, focusing on market opportunities in neighboring regions.
Each segment exhibits distinct purchasing behaviors: distributors and contract manufacturers prioritize bulk procurement to optimize economies of scale, retail chains focus on maintaining adequate stock levels to meet consumer demand, and re-exporters strategize purchases based on international market dynamics.
Country-Specific Import Regulations
TransData Nexus Fenofibrate buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries of Fenofibrate from India, the import regulations are as follows:
1. United States:
2. Belgium:
3. Australia:
4. South Korea:
5. France:
Demand Drivers & Market Opportunity
TransData Nexus Fenofibrate buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Fenofibrate in importing countries is driven by several factors:
1. Disease Prevalence: Fenofibrate is primarily used to treat hypercholesterolemia and hypertriglyceridemia. The increasing prevalence of cardiovascular diseases globally has led to a higher demand for lipid-regulating agents like Fenofibrate.
2. Government Healthcare Programs: Many countries have implemented programs to manage and prevent cardiovascular diseases, which include the provision of essential medicines like Fenofibrate.
3. Universal Health Coverage Expansion: The expansion of universal health coverage in various countries has improved access to essential medicines, increasing the demand for affordable generic drugs such as Fenofibrate.
4. WHO Essential Medicines List Procurement: While Fenofibrate is not listed on the WHO Model List of Essential Medicines, its inclusion in national essential medicines lists can influence procurement decisions, especially in countries aligning their lists with WHO recommendations.
5. Tender-Based Purchasing: Public sector procurement often involves tendering processes to ensure cost-effective purchasing of medicines. The competitive nature of these tenders can drive demand for affordable generic versions of Fenofibrate.
With 368 buyers across 81 countries, the market for Fenofibrate imported from India demonstrates significant global reach. The repeat buyer rate of 59.5% indicates a stable demand, suggesting opportunities for sustained market engagement and potential growth in emerging markets.
Common Questions — Fenofibrate Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest fenofibrate buyer importing from India?
Based on import volume and value, YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM) leads with $6.2M in imports and a 8.4% market share — the highest of any single fenofibrate importer. MYLAN HUNGARY KFT (FRANCE) and LIFESTAR PHARMA LLC (UNITED STATES) are the next largest buyers.
QHow many companies buy fenofibrate from India?
There are 368 active fenofibrate buyers importing from India, with a combined market of $73.4M across 2,794 shipments to 81 countries. The top 5 buyers hold 32.3% of total import value, while the remaining 363 buyers handle the other 67.7%.
QWhich countries import the most fenofibrate from India?
The top importing countries for fenofibrate from India are United States (43.4%), Belgium (8.7%), Australia (8.2%), South Korea (6.4%), France (6.4%). These markets represent the largest demand centres for Indian pharmaceutical exports of fenofibrate, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for fenofibrate from India?
The average import transaction value for fenofibrate from India is $26.3K, with an average unit price of $8.19 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Fenofibrate buyer market intelligence
1Buyer Segment Analysis
The importers of Fenofibrate from India can be categorized into several key segments:
1. Distributors: Entities like YUSEN LOGISTICS BENELUX BELGIUM and MYLAN HUNGARY KFT fall into this category. These organizations purchase large quantities of Fenofibrate to distribute across various markets, ensuring a steady supply chain to meet regional demands. Their buying behavior typically involves bulk orders with a focus on cost-effectiveness and timely delivery.
2. Contract Manufacturers: Companies such as MYLAN LABORATORIES SAS and AMNEAL PHARMACEUTICALS, LLC (KY) serve as contract manufacturers. They procure Fenofibrate to produce finished pharmaceutical products under contract for other brands or for their own distribution. Their procurement patterns are aligned with production schedules and client demands, often involving consistent, large-volume purchases.
3. Retail Chains: Entities like LIFESTAR PHARMA LLC and CIPLA USA INC UPS SUPPLY CHAIN SOLU represent retail chains. They import Fenofibrate to supply their retail outlets, ensuring product availability for end consumers. Their purchasing behavior is influenced by consumer demand trends, leading to regular orders that align with market consumption rates.
4. Re-exporters: Companies such as ARROW PHARMACEUTICALS PTY LTD and AJANTA PHARMA PHILIPPINES INC act as re-exporters. They import Fenofibrate with the intention of exporting it to other countries, often leveraging favorable trade agreements or regional demand. Their order patterns are strategic, focusing on market opportunities in neighboring regions.
Each segment exhibits distinct purchasing behaviors: distributors and contract manufacturers prioritize bulk procurement to optimize economies of scale, retail chains focus on maintaining adequate stock levels to meet consumer demand, and re-exporters strategize purchases based on international market dynamics.
Country-Specific Import Regulations
TransData Nexus Fenofibrate buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries of Fenofibrate from India, the import regulations are as follows:
1. United States:
2. Belgium:
3. Australia:
4. South Korea:
5. France:
Demand Drivers & Market Opportunity
TransData Nexus Fenofibrate buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Fenofibrate in importing countries is driven by several factors:
1. Disease Prevalence: Fenofibrate is primarily used to treat hypercholesterolemia and hypertriglyceridemia. The increasing prevalence of cardiovascular diseases globally has led to a higher demand for lipid-regulating agents like Fenofibrate.
2. Government Healthcare Programs: Many countries have implemented programs to manage and prevent cardiovascular diseases, which include the provision of essential medicines like Fenofibrate.
3. Universal Health Coverage Expansion: The expansion of universal health coverage in various countries has improved access to essential medicines, increasing the demand for affordable generic drugs such as Fenofibrate.
4. WHO Essential Medicines List Procurement: While Fenofibrate is not listed on the WHO Model List of Essential Medicines, its inclusion in national essential medicines lists can influence procurement decisions, especially in countries aligning their lists with WHO recommendations.
5. Tender-Based Purchasing: Public sector procurement often involves tendering processes to ensure cost-effective purchasing of medicines. The competitive nature of these tenders can drive demand for affordable generic versions of Fenofibrate.
With 368 buyers across 81 countries, the market for Fenofibrate imported from India demonstrates significant global reach. The repeat buyer rate of 59.5% indicates a stable demand, suggesting opportunities for sustained market engagement and potential growth in emerging markets.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 368 global importers of Fenofibrate identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 2,794 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 81 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2,794 Verified Shipments
368 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists